The human T-cell leukemia virus type 1 (HTLV-1) is the cause of serious malignant and inflammatory diseases, including adult T-cell leukemia and lymphoma and tropical spastic paraparesis. The potential protective role of γδ T cells in HTLV-1 infection remains unclear. Here, demonstrate that there is a decrease in the amount of Vγ9Vδ2 T cells in patients with HTLV-1, especially in those with HTLV-1 associated pathologies. This suggests that γδ T cells could be involved in controlling the virus. Indeed, we found that Vγ9Vδ2 T cells, expanded from non-infected individuals, can kill cells expressing the viral proteins HBZ and Tax and this phenotype is reversed in the presence of mevastatin. Cytotoxicity by Vγ9Vδ2 T cells was not associated with an increase of INF-γ production. In sharp contrast, killing by NK cells was reduced by Tax expression. Thus, our study provides initial evidence for a potential protective role of Vγ9Vδ2 T cells against HTLV-1 infection. Therapeutic exploitation of these insights is feasible with current technologies of T-cell therapies and could provide novel tools to prevent and treat HTLV-1-associated malignancies and neurologic complications.
- Ruggieri, M.
- Ducasa, N.
- Juraske, C.
- Polo, V. G.
- Berini, C.
- Quiroga, M. F.
- Christopoulos, P.
- Minguet, S.
- Biglione, M.
- Schamel, W. W.
Keywords
- Adult
- *HTLV-I Infections
- *Human T-lymphotropic virus 1
- Humans
- *Paraparesis, Tropical Spastic
- Phenotype
- T-Lymphocytes
- Htlv-1
- Ifn-γ
- cytotoxicity
- mevalonate pathway
- γδ T cells